risk of osteoporotic fractures in children and youth ages 4 to 17 years (PICO 7.1a-7.5a). For children and youth ages 4 to 17 years with an osteoporotic fracture who are continuing treatment with chronic GC at a dose of â‰¥0.1 mg/kg/day for >3 months, treating with an oral or IV BP is conditionally recommended over no treatment.  This conditional recommendation to treat with oral or IV BP to prevent recurrent fractures is based on low-certainty evidence. Depending on the specific disease or cause